From standard medications to advanced drug delivery, surgery, and regenerative approaches, Parkinson's treatment options in ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain ...

BlueRock Therapeutics, a Bayer subsidiary developing stem cell treatments for Parkinson’s disease, has partnered with Rune Labs to collect Apple Watch sensor data during clinical trials of its ...

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Scientists at the University of Edinburgh in Scotland used biologically-engineered E. coli, a bacteria that causes diarrhea, ...

A drug to treat Parkinson's disease can be made from waste plastic bottles using a pioneering method, a study shows. The approach harnesses the power of bacteria to transform post-consumer plastic ...

Scientists engineer E. coli to convert PET plastic bottle waste into L-DOPA, a primary treatment for Parkinson’s disease.

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

Ambroxol showed target engagement in Parkinson's dementia but no significant cognitive improvement over placebo. The drug, a common cough medicine in Europe, was safe and well-tolerated. Ambroxol ...